Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetics and Molecular Pathology, |
RCV002466791 | SCV002761448 | uncertain significance | Pseudo von Willebrand disease | 2020-03-02 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV003164725 | SCV003869400 | uncertain significance | Inborn genetic diseases | 2023-02-07 | criteria provided, single submitter | clinical testing | The c.1775G>A (p.R592Q) alteration is located in exon 2 (coding exon 1) of the GP1BA gene. This alteration results from a G to A substitution at nucleotide position 1775, causing the arginine (R) at amino acid position 592 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |